JP Morgan Private Wealth Advisors’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$93.6K Sell
10,289
-110
-1% -$1.32K ﹤0.01% 1688
2023
Q2
$127K Sell
10,399
-17,706
-63% -$197K ﹤0.01% 1429
2023
Q1
$349K Buy
28,105
+465
+2% +$8.55K ﹤0.01% 1614
2022
Q4
$531K Buy
27,640
+30
+0.1% +$634 ﹤0.01% 1453
2022
Q3
$519K Buy
27,610
+2,620
+10% +$53.9K ﹤0.01% 1438
2022
Q2
$451K Buy
24,990
+924
+4% +$15K ﹤0.01% 1496
2022
Q1
$386K Buy
24,066
+10,956
+84% +$197K ﹤0.01% 1642
2021
Q4
$321K Buy
13,110
+1,233
+10% +$28.9K ﹤0.01% 1725
2021
Q3
$277K Buy
11,877
+2,783
+31% +$67.3K ﹤0.01% 1724
2021
Q2
$249K Sell
9,094
-3,671
-29% -$105K ﹤0.01% 1742
2021
Q1
$469K Buy
+12,765
New +$451K ﹤0.01% 1338

Other funds holding AHCO

JP Morgan Private Wealth Advisors's AHCO Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors reduced its AdaptHealth (AHCO) stake by 1.1% in Q3 2023, selling an estimated $1.32K and leaving 10,289 shares worth $93.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1688.

JP Morgan Private Wealth Advisors first reported a position in AHCO in Q1 2021 and has held it in 11 quarters since. The position peaked at $531K in Q4 2022. 191 funds tracked by Wall St. Rank hold AHCO as of Q3 2023.

  • JP Morgan Private Wealth Advisors held 10,289 shares of AdaptHealth worth $93.6K as of Q3 2023.
  • JP Morgan Private Wealth Advisors sold 110 AdaptHealth shares in Q3 2023, an estimated $1.32K.
  • AdaptHealth made up ﹤0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #1688 holding.
  • JP Morgan Private Wealth Advisors first reported a position in AdaptHealth in Q1 2021 and has held it in 11 quarters since.
  • JP Morgan Private Wealth Advisors's AdaptHealth position peaked at $531K in Q4 2022.
  • 191 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.